GLP-1s for Polyendocrine Metabolic Ovarian Syndrome Women with polyendocrine metabolic ovarian syndrome (PMOS) produce excess testosterone, which can lead to painful, heavy, or irregular periods, infertility, excess facial and body hair, severe acne, and small cysts on the ovaries
Complementary effects to more targeted peptides
It helps manage blood sugar levels by mimicking the GLP-1 hormone that your body naturally produces
They found that achieving 10% weight loss outweighed the cumulative risks, with a net benefit probability of 0.97 at year 1 and 0.91 at year 2
CONTRAINDICATIONS According to the package insert, Wegovy is contraindicated in patients with the following: personal or family history of Medullary Thyroid Carcinoma patients with Multiple Endocrine Neoplasm type 2 patients with a prior serious hypersensitivity reaction to semaglutide or to any of the excipients in Wegovy
Eden Flexible Access ~$279/mo #9